Confidentiality in a China Drug Master File (DMF) is maintained through strict regulatory controls, including secure submission processes, restricted access to sensitive information, and adherence to legal agreements. Regulatory authorities ensure that proprietary data is protected, allowing only authorized personnel to review the information necessary for drug approval processes.
